Download PDF

Register to download the report. Already a member?

 
 
Sign Up

Or

63850 1504871583HCLSReviewHongKongSeptember2017.pdf
Energy Boardroom

AZ's Forxiga and Taiho's Lonsurf get Japanese approval

24.03.2014 / Scripintelligence

The MHLW has approved AstraZeneca's sodium-glucose co-transporter 2 (SGLT2) inhibitor Forxiga (dapagliflozin 5mg and 10mg tablets), as a once-daily oral treatment for type 2 diabetes. The application was submitted to the MHLW by Bristol-Myers Squibb….

LATEST ISSUE

DOWNLOAD

X
Download PDF

First Name:

Last Name:

Company:

Position:

Country:

Email: